Company Profile
Videregen Limited
07573593•Private Limited With Share Capital
Get Full Access
22/03/2011
15 years
3
5
74909
moderate risk
Company Overview
Registration, classification & business activity
Videregen Limited (07573593) is a private limited with share capital incorporated on 22/03/2011 (15 years old) and registered in chester, CH49QN. The company operates under SIC code 74909 - other professional, scientific and technical activities n.e.c..
A leader in the restoration and regeneration of tissue function, videregen is a clinical stage company with a primary focus on treating airway diseases and thymus dysfunction. thymus dysfunction is implicated in a number of immune disorders and age-related diseases. videregen utilises its proprietar...
Financial Overview
£165.7K
£153.6K
£12.1K
£27.9K
Key Metrics
5
Employees
3
Directors
32
Shareholders
Board of Directors
Innovate Grants
This company received a grant of £805821.1 for Autologous Stem-Cell Based Tissue Engineered Treatment For Bronchopleural Fistula. The project started on 01/11/2018 and ended on 31/03/2022.
This company received a grant of £249000.0 for Continuity Grant Support For Autologous Stem-Cell Based Tissue Engineered Treatment For Bronchopleural Fistula. The project started on 01/06/2020 and ended on 31/03/2021.
+3 more grants available
Import / Export
Risk Assessment
moderate risk
International Score
Future Factor
good
Performance Rating